Showing results (71-80 of 611) with videos related to
Sort By:
Pageof 62
Presse Medicale (Paris, France : 1983)|March 15, 1986
[Course of the manifestations associated with the antiprothrombinase circulating anticoagulant]A Camez, G Tobelem, S Bellucci, et al.Thrombosis and Haemostasis|August 30, 1988
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activationR Cariou, G Tobelem, S Bellucci, et al.Nouvelle Revue Francaise D'Hematologie|March 1, 1975
[Hereditary hypogranular thrombocytopathic thrombocytopenia. Ultrastructural study of a megakaryocytopathy (author's transl)]J Libánská, L Falcão, A Gautier, et al.Presse Medicale (Paris, France : 1983)|January 15, 1983
[Molecular abnormalities in recurrent thromboembolic disease]E Dupuy, G Tobelem, C Soria, et al.International Archives of Allergy and Applied Immunology|January 1, 1985
New functions for platelets and their pathological implicationsA Capron, J C Ameisen, M Joseph, et al.Pathology|January 1, 1991
Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometryS O Brennan, J Y Borg, G J Shaw, et al.Blood|August 9, 2001
Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the responseJ Levin, L Cocault, C Demerens, et al.Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndromeS Béguin, I Keularts, R Al Dieri, et al.Journal of Cellular Biochemistry|September 15, 1996
Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cellsF Incardona, J Lawler, D Cataldo, et al.Blood|May 1, 1987
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisM C Owen, J Y Borg, C Soria, et al.Pageof 62